210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Reports Second Quarter 2026 Financial Results and Business Update
Material disclosure
CEO Appointment - Zachary Roberts Named President and CEO of Allogene Therape...
Reports First Quarter 2026 Financial Results and Business Update
Annual Report to Security Holders
Announces Pricing of Public Offering of Common Stock
Other Events
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report